This page provides centralized resources for those seeking information about the ROADS clinical trial. Explore the latest announcements, peer-reviewed clinical publications, educational materials, messaging resources, and multimedia assets related to the trial and its findings.
Press Releases
Key announcements and milestones related to the ROADS clinical trial
Publication of ROADS Phase 3 Clinical Trial Data in Journal of Clinical Oncology Recommends GammaTile® as a New Standard-of-Care Option for Newly Diagnosed Operable Brain Metastases
ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases
ASCO: Tile-Based Radiation Therapy Lowers Risk of Recurrence in Brain Metastases (The University of Texas MD Anderson Cancer Center)
Implanted Tile-Based Radiation Outperforms Stereotactic Radiotherapy for Treatment of Brain Metastases (ASCO)
Clinical Data
Abstracts, presentations and publications related to the ROADS clinical trial
ROADS Phase 3 Results Published in Journal of Clinical Oncology
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial
Media Inquiries
For media inquiries and GammaTile Key Opinion Leader (KOL) interviews:
